标题
CD19 as a molecular target in CNS autoimmunity
作者
关键词
Multiple Sclerosis, Chronic Lymphocytic Leukemia, Maximum Tolerate Dose, Multiple Sclerosis Lesion, Annualize Relapse Rate
出版物
ACTA NEUROPATHOLOGICA
Volume 128, Issue 2, Pages 177-190
出版商
Springer Nature
发表日期
2014-07-03
DOI
10.1007/s00401-014-1313-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G
- (2014) Nithi Asavapanumas et al. Journal of Neuroinflammation
- Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
- (2014) Ludwig Kappos et al. LANCET NEUROLOGY
- IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
- (2014) Ping Shen et al. NATURE
- Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease
- (2014) V. Kraus et al. NEUROLOGY
- Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study
- (2014) P. S. Sorensen et al. NEUROLOGY
- Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
- (2014) D. K. Sato et al. NEUROLOGY
- Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies
- (2014) Joanna Kitley et al. JAMA Neurology
- Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica
- (2013) Julien Ratelade et al. ACTA NEUROPATHOLOGICA
- Monoclonal antibodies in treatment of multiple sclerosis
- (2013) P. S. Rommer et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- B-cell biology and development
- (2013) Kathrin Pieper et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The mechanism of anti-CD20–mediated B cell depletion revealed by intravital imaging
- (2013) Fabricio Montalvao et al. JOURNAL OF CLINICAL INVESTIGATION
- Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica
- (2013) Y. Jiao et al. NEUROLOGY
- Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges
- (2013) Klaus Lehmann-Horn et al. Therapeutic Advances in Neurological Disorders
- Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trial
- (2012) William Stohl et al. ANNALS OF THE RHEUMATIC DISEASES
- Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
- (2012) Ingo Kleiter ARCHIVES OF NEUROLOGY
- B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
- (2012) Matthieu Mahévas et al. JOURNAL OF CLINICAL INVESTIGATION
- A c-Myc and Surface CD19 Signaling Amplification Loop Promotes B Cell Lymphoma Development and Progression in Mice
- (2012) J. C. Poe et al. JOURNAL OF IMMUNOLOGY
- Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
- (2012) Sven Jarius et al. Journal of Neuroinflammation
- Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success
- (2012) Benjamin M Greenberg et al. Multiple Sclerosis Journal
- Paucity of natural killer and cytotoxic T cells in human neuromyelitis optica lesions
- (2012) Samira Saadoun et al. NEUROREPORT
- Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis
- (2012) Rajneesh Srivastava et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity
- (2012) Henrik E Mei et al. ARTHRITIS RESEARCH & THERAPY
- Rituximab combination therapy in relapsing multiple sclerosis
- (2012) Anne H. Cross et al. Therapeutic Advances in Neurological Disorders
- Repeated Treatment With Rituximab Based on the Assessment of Peripheral Circulating Memory B Cells in Patients With Relapsing Neuromyelitis Optica Over 2 Years
- (2011) Su-Hyun Kim ARCHIVES OF NEUROLOGY
- Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels
- (2011) Ichiro Nakashima et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures
- (2011) S. Jarius et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
- (2011) H. L. Pellkofer et al. NEUROLOGY
- Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
- (2011) Norio Chihara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Epstein-Barr virus and multiple sclerosis: epidemiological evidence
- (2010) A. Ascherio et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
- (2010) Paul A. Blair et al. IMMUNITY
- B-Cell Depletion In Vitro and In Vivo with an Afucosylated Anti-CD19 Antibody
- (2010) R. Herbst et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Ofatumumab
- (2010) Bodi Zhang mAbs
- Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes
- (2010) John DE Parratt et al. Multiple Sclerosis Journal
- Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6
- (2010) Akiyuki Uzawa et al. Multiple Sclerosis Journal
- IFN -1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum
- (2010) J. Shimizu et al. NEUROLOGY
- Atacicept: targeting B cells in multiple sclerosis
- (2010) Hans-Peter Hartung et al. Therapeutic Advances in Neurological Disorders
- Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
- (2009) Monika Bradl et al. ANNALS OF NEUROLOGY
- Intrathecal pathogenic antiâaquaporin-4 antibodies in early neuromyelitis optica
- (2009) Jeffrey L. Bennett et al. ANNALS OF NEUROLOGY
- Epstein–Barr virus infection is not a characteristic feature of multiple sclerosis brain
- (2009) Simon N. Willis et al. BRAIN
- Ocrelizumab: a step forward in the evolution of B-cell therapy
- (2009) Fariha Kausar et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Nonredundant Roles for B Cell-Derived IL-10 in Immune Counter-Regulation
- (2009) R. Madan et al. JOURNAL OF IMMUNOLOGY
- CD19: a promising B cell target for rheumatoid arthritis
- (2009) Thomas F. Tedder Nature Reviews Rheumatology
- Treatment of Neuromyelitis Optica With Rituximab
- (2008) ARCHIVES OF NEUROLOGY
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More